Are you confused about whether to apply for the Lenskart IPO or not? Here are all its strengths, risks and business strategies, based on brokerage analyses: ...

Award recognizes the groundbreaking science of Dupixent and its transformational impact on multiple rare and common allergic and atopic conditions First and only therapy to specifically target the ...